Polypharmacy in patients with multiple sclerosis: a gender-specific analysis

ConclusionMale and female MS patients with older age, comorbidities, higher disability degree, and inpatient treatment are at greater risk of polypharmacy. Future studies should examine the occurrence of clinically relevant drug interactions in MS patients stratified by sex.
Source: Biology of Sex Differences - Category: Biology Source Type: research